knowledge -WSS

knowledge

author：comprehensive 2025-09-27 13:10:20 - browse：197

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Friends ask where James Watson's attitudes about race came from

hotspot

WSS

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Eliminate the waiting period for sterilization covered by Medicaid

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Steward Health Care has deal to sell doctor network to UnitedHealth

Vertex Pharmaceuticals may move headquarters in Boston

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Psychedelics group wrestles with new pharma identity

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Hollywood unions extend contract negotiations for actors

Merck drug for rare lung condition set for approval in U.S.

Apple is now the first public company to be valued at $3 trillion

Drastic changes should bring profitability, startup health insurers say

ChatGPT in medicine: STAT answers readers' burning questions

Abortion pill case raises question: who can sue the FDA?

Peter Hotez and the public health issue of online harassment

American woman, child freed after being kidnapped in Haiti last month

entertainment

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

There's no autism epidemic. It's an autism diagnosis epidemic

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

The Readout: Lenmeldy, GLP

NIH trials fail to test meaningful long Covid therapies, experts say

explore

explore

hotspot

explore